2025
SJR Q1
JCR Q1 · 5,1
8 matched articles
SCIE
Journal detail
Targeted Oncology
- Country
- Switzerland · Western Europe
- Type
- journal
- ISSN
-
177625961776260X
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 1,435
- Quartile Q1
- H-Index 65
- Cites/doc 4,15
- Docs (3y) 229
- Cites (3y) 831
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 5,1
- 5Y JIF 5
- JCI 0,83
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Cancer Research Q2
- Oncology Q1
- Pharmacology (medical) Q1
Areas
- Biochemistry, Genetics and Molecular Biology
- Medicine
WoS categories
- Oncology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 1,435 | 5,1 | 5 | 0,83 | Q2 | 65 |
| 2024 | Q1 | Q2 | 1,645 | 4 | 4,4 | 0,92 | Q2 | 63 |
| 2023 | Q1 | Q2 | 1,421 | 4,4 | 3,9 | 0,85 | Q2 | 63 |
| 2022 | Q1 | Q2 | 1,46 | 5,4 | 4,8 | 0,92 | Q2 | 63 |
| 2021 | Q1 | Q2 | 1,233 | 4,9 | 4,7 | 0,76 | Q2 | 63 |
| 2020 | Q1 | Q2 | 1,697 | 4,5 | 4,4 | 0,79 | Q2 | 63 |
| 2019 | Q1 | Q2 | 1,442 | 4 | 3,5 | 0,79 | Q2 | 63 |
| 2018 | — | Q2 | — | 3,7 | 3,1 | 0,86 | Q2 | — |
| 2017 | Q1 | Q2 | 1,304 | 3,9 | 3,3 | 0,85 | Q2 | 63 |
| 2016 | Q1 | Q2 | 1,081 | 3,4 | 3,3 | — | — | 63 |
| 2015 | Q1 | Q2 | 1,4 | 3,2 | 3 | — | — | 63 |
| 2014 | Q1 | Q2 | 1,405 | 4 | 3,5 | — | — | 63 |
| 2013 | Q1 | Q2 | 1,327 | 3,5 | 2,7 | — | — | 63 |
| 2012 | Q1 | Q2 | 1,453 | 2,8 | 2 | — | — | 63 |
| 2011 | Q1 | Q2 | 0,985 | 3,6 | 1,7 | — | — | 63 |
| 2010 | Q2 | Q3 | 0,633 | 2,1 | 1,2 | — | — | 63 |
| 2009 | — | Q4 | — | 0,5 | 0,5 | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | ONCOLOGY | SCIE | Q1 | Q2 | 83/333 |
| 2024 | ONCOLOGY | SCIE | Q2 | Q2 | 97/328 |
| 2023 | ONCOLOGY | SCIE | Q2 | Q2 | 87/322 |
| 2022 | ONCOLOGY | SCIE | Q2 | Q2 | 69/241 |
| 2021 | ONCOLOGY | SCIE | Q2 | Q2 | 97/245 |
| 2020 | ONCOLOGY | SCIE | Q2 | Q2 | 105/242 |
| 2019 | ONCOLOGY | SCIE | Q2 | Q2 | 88/244 |
| 2018 | ONCOLOGY | SCIE | Q2 | Q2 | 80/230 |
| 2017 | ONCOLOGY | SCIE | Q2 | Q2 | 75/223 |
| 2016 | ONCOLOGY | SCIE | Q2 | — | 87/217 |
| 2015 | ONCOLOGY | SCIE | Q2 | — | 88/213 |
| 2014 | ONCOLOGY | SCIE | Q2 | — | 58/211 |
| 2013 | ONCOLOGY | SCIE | Q2 | — | 70/203 |
| 2012 | ONCOLOGY | SCIE | Q2 | — | 90/197 |
| 2011 | ONCOLOGY | SCIE | Q2 | — | 56/196 |
| 2010 | ONCOLOGY | SCIE | Q3 | — | 116/185 |
| 2009 | ONCOLOGY | SCIE | Q4 | — | 154/166 |